대시보드포트폴리오관심 목록커뮤니티발견스크리너
NOT FOR DISTRIBUTION
Loading...
  • 주식
  • /
  • 소재
1분 전 업데이트
530999 logo

Balaji Amines LimitedBSE:530999 주식 보고서

시가총액 ₹68.3b
1분 전 업데이트
주가
n/a
1Y38.9%
7D-14.4%
1D-7.3%
포트폴리오 가치
​
보기

Balaji Amines Limited

BSE:530999 주식 리포트

시가총액: ₹68.3b

  • 회사 개요
    • 가치 평가
    • 미래 성장
    • 과거 실적
    • 재무 건전성
    • 배당
  • 경영진
  • 지분
  • 기타 정보
  • 주식 커뮤니티

Balaji Amines (530999) 주식 개요

발라지 아민스는 인도에서 메틸아민, 에틸아민, 특수 화학물질 및 제약 부형제의 파생물을 제조 및 판매하는 회사입니다. 자세히 보기

530999 펀더멘털 분석
스노우플레이크 점수
가치 평가1/6
미래 성장3/6
과거 실적4/6
재무 건전성6/6
배당4/6

강점

수익은 매년 17.7% 증가할 것으로 예상됩니다.

지난 1년간 수익이 34.1% 증가했습니다.

위험 분석

지난 3개월 동안 주가 변동성이 Indian 시장과 비교해 높았습니다.

0.52% 의 배당금은 잉여현금흐름으로 잘 충당되지 않습니다.


530999 Community Fair Values

Create Narrative

See what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
1.1% 고평가 내재 할인율
AnalystConsensusTarget
•1mo ago

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

115
0
1
AN
AnalystLowTarget
58.1% 고평가 내재 할인율
AnalystLowTarget
•4mo ago

Chinese Dumping And Cost Spikes Will Erode Margins Despite Expansion

35
0
0
AN
AnalystHighTarget
36.6% 저평가 내재 할인율
AnalystHighTarget
•2mo ago

New Plants Will Fuel Rising Pharma Demand And Export Surge

34
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
1.1% 고평가 내재 할인율
AnalystConsensusTarget
•1mo ago

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

115
0
1
AN
AnalystLowTarget
58.1% 고평가 내재 할인율
AnalystLowTarget
•4mo ago

Chinese Dumping And Cost Spikes Will Erode Margins Despite Expansion

35
0
0
AN
AnalystHighTarget
36.6% 저평가 내재 할인율
AnalystHighTarget
•2mo ago

New Plants Will Fuel Rising Pharma Demand And Export Surge

34
0
0
View all narratives

Balaji Amines Limited 경쟁사

Archean Chemical Industries

Symbol: NSEI:ACI
Market cap: ₹56.2b

Alkyl Amines Chemicals

Symbol: BSE:506767
Market cap: ₹90.8b

Neogen Chemicals

Symbol: NSEI:NEOGEN
Market cap: ₹63.3b

Jubilant Ingrevia

Symbol: NSEI:JUBLINGREA
Market cap: ₹103.8b

가격 이력 및 성과

Balaji Amines 주가의 최고가, 최저가 및 변동 요약
과거 주가
현재 주가₹2,109.20
52주 최고가₹2,627.95
52주 최저가₹905.15
베타0.86
1개월 변동-0.96%
3개월 변동-2.10%
1년 변동38.87%
3년 변동-5.23%
5년 변동-54.68%
IPO 이후 변동16,726.49%

최근 뉴스 및 업데이트

User avatar
내러티브 업데이트 • Jul 23

530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside

The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.
User avatar
내러티브 업데이트 • Jul 09

530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure

Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.

Recent updates

User avatar
내러티브 업데이트 • Jul 23

530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside

The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.
User avatar
내러티브 업데이트 • Jul 09

530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure

Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.
User avatar
내러티브 업데이트 • Jun 18

530999: Higher P E And Weaker Margins Will Pressure Future Returns

Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
User avatar
내러티브 업데이트 • May 21

530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism

Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
User avatar
내러티브 업데이트 • May 07

530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside

Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.
User avatar
내러티브 업데이트 • Apr 23

530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside

Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.
User avatar
내러티브 업데이트 • Apr 08

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
User avatar
내러티브 업데이트 • Mar 24

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.
User avatar
내러티브 업데이트 • Mar 10

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).
User avatar
내러티브 업데이트 • Feb 23

530999: Higher Future P E And Margins Will Likely Support Returns

Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.
User avatar
내러티브 업데이트 • Feb 09

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
User avatar
내러티브 업데이트 • Jan 25

530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins

Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).
User avatar
내러티브 업데이트 • Jan 10

530999: Stable Margins And Upcoming Results Will Support Further Upside

Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).
User avatar
내러티브 업데이트 • Dec 25

530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins

Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.
User avatar
내러티브 업데이트 • Dec 11

530999: Stable Margins And Growth Outlook Will Support Further Upside

Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
User avatar
내러티브 업데이트 • Nov 27

530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales

Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.
User avatar
내러티브 업데이트 • Sep 05

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
User avatar
새로운 내러티브 • Feb 02

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.

주주 수익률

530999IN ChemicalsIN 시장
7D-14.4%-0.8%-1.0%
1Y38.9%-1.6%-1.4%

수익률 대 산업: 530999은 지난 1년 동안 -1.6%의 수익을 기록한 Indian Chemicals 산업보다 더 좋은 성과를 냈습니다.

수익률 대 시장: 530999은 지난 1년 동안 -1.4%를 기록한 Indian 시장보다 더 좋은 성과를 냈습니다.

주가 변동성

Is 530999's price volatile compared to industry and market?
530999 volatility
530999 Average Weekly Movement8.0%
Chemicals Industry Average Movement5.8%
Market Average Movement5.7%
10% most volatile stocks in IN Market8.9%
10% least volatile stocks in IN Market3.4%

안정적인 주가: 530999의 주가는 지난 3개월 동안 Indian 시장보다 변동성이 컸습니다.

시간에 따른 변동성: 530999의 주간 변동성(8%)은 지난 1년 동안 안정적이었지만 Indian 종목 중 상위 75%보다 높습니다.

회사 소개

설립직원 수CEO웹사이트
19881,161Dundurapu Reddywww.balajiamines.com

발라지 아민스는 인도에서 메틸아민, 에틸아민, 특수 화학물질 및 제약 부형제의 유도체 제조 및 판매에 종사하고 있습니다. 이 회사는 화학 및 호텔의 두 부문으로 운영됩니다. 모노메틸아민, 디메틸아민, 트리메틸아민, 모노에틸아민, 디에틸아민, 트리에틸아민, 디메틸 아미노 에탄올과 N-메틸 피롤리돈, 모르폴린, 2-피롤리돈, N-에틸-2-피롤리돈, 감마-부틸락톤, 디메틸포름아마이드, 아세토니트릴, 디메틸탄산염, 프로필렌 글리콜, 프로필렌 탄산염 등 특수 화학 물질을 공급하고 있습니다.

Balaji Amines Limited 기초 지표 요약

Balaji Amines의 순이익과 매출은 시가총액과 어떻게 비교됩니까?
530999 기초 통계
시가총액₹68.34b
순이익 (TTM)₹2.04b
매출 (TTM)₹15.23b
33.5x
주가수익비율(P/E)
4.5x
주가매출비율(P/S)

530999는 고평가되어 있습니까?

공정 가치 및 평가 분석 보기

순이익 및 매출

최근 실적 보고서(TTM)의 주요 수익성 지표
530999 손익계산서 (TTM)
매출₹15.23b
매출원가₹8.44b
총이익₹6.78b
기타 비용₹4.74b
순이익₹2.04b

최근 보고된 실적

Jun 30, 2026

다음 실적 발표일

해당 없음

주당순이익(EPS)63.00
총이익률44.54%
순이익률13.41%
부채/자본 비율6.2%

530999의 장기 실적은 어땠습니까?

과거 실적 및 비교 보기

배당

0.5%
현재 배당 수익률
21%
배당 성향

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/09/15 16:56
종가2026/09/15 00:00
수익2026/06/30
연간 수익2026/03/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
  • SEC 양식 10-K
  • SEC 양식 10-Q
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
  • 분석가 리서치 보고서
  • Blue Matrix
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
  • ICE 시장 데이터
  • SEC 양식 S-1
지분 구조10년
  • 주요 주주
  • 내부자 거래
  • SEC 양식 4
  • SEC 양식 13D
경영진10년
  • 리더십 팀
  • 이사회
  • SEC 양식 10-K
  • SEC 양식 DEF 14A
주요 개발10년
  • 회사 공시
  • SEC 양식 8-K

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Balaji Amines Limited는 4명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Nilesh GhugeHDFC Securities Limited
Jay GandhiHDFC Securities Limited
Keshav LahotiHDFC Securities Limited

어디서든 더 나은 투자 결정을 내리세요

스캔하여 다운로드
App Store 열기Google Play 열기
Chrome 웹 스토어
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
데이터 소스 보기
시장
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
투자 아이디어
  • 저평가 기업
  • 고배당 우량주
  • 임원 매수
  • 원자력 에너지
  • 자율주행차
  • 인공지능
  • 암호화폐 및 블록체인
  • 사이버보안
  • 더 많은 아이디어
주식 커뮤니티
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
기능 및 도구
  • 포트폴리오 추적기
  • 주식 스크리너 & 알림
  • 내러티브 및 적정 가치
  • 배당 계산기
뉴스 및 탐색
  • 최신 주식 뉴스
  • 글로벌 시장 인사이트
  • 더 폭스홀
  • 투자 아이디어
  • 커뮤니티 스토리
  • 새로운 소식
Simply Wall St
  • 플랜 및 가격
  • 광고
  • 회사 소개
  • 문의하기
  • 채용
  • 도움말 센터
  • 주식 투자 학습
  • 제휴 프로그램
  • 비즈니스 & 엔터프라이즈
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • 이용 약관
  • 개인정보처리방침
  • AI 약관
  • 금융 서비스 가이드